Early antipsychotic treatment in childhood/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats

Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways

(2015) Jiamei Lian et al.   PHARMACOLOGICAL RESEARCH

Risperidone for non-psychotic disorders in paediatric patients: which child is to benefit?

(2014) Pieter J Hoekstra   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

The use of antipsychotics in preschoolers: A veto or a sensible last option?

(2014) Jessica Memarzia et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antipsychotics use in children and adolescents: An on-going challenge in clinical practice

(2014) Carolina Schneider et al.   JOURNAL OF PSYCHOPHARMACOLOGY

GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats

(2014) Ajaykumar N. Sharma et al.   METABOLIC BRAIN DISEASE

Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain

(2014) Duncan Sinclair et al.   PSYCHOPHARMACOLOGY

Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function

(2013) Monika Vinish et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: A preclinical test in the phencyclidine hyperlocomotion model

(2013) Qing Shu et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats

(2013) Fausto A Varela et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Olanzapine Treatment of Adolescent Rats Causes Enduring Specific Memory Impairments and Alters Cortical Development and Function

(2013) Jean A. Milstein et al.   PLoS One

A proposal for refining the forced swim test in Swiss mice

(2013) Ana Paula Ramos Costa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

(2012) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra

(2012) Tertia D Purves-Tyson et al.   BMC NEUROSCIENCE

Antipsychotics for Children and Young Adults: A Comparative Effectiveness Review

(2012) J. C. Seida et al.   PEDIATRICS

Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies

(2011) Alessandro Zuddas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?

(2011) Susan L. Andersen et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Efficacy of Risperidone in Managing Maladaptive Behaviors for Children With Autistic Spectrum Disorder: A Meta-Analysis

(2011) Akanksha Sharma et al.   Journal of Pediatric Health Care

Lasting effects of chronic fluoxetine treatment on the late developing rat brain: Age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI

(2011) A. Klomp et al.   NEUROIMAGE

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

(2011) J.-M. Beaulieu et al.   PHARMACOLOGICAL REVIEWS

The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia

(2011) Andrea Gogos et al.   PSYCHOPHARMACOLOGY

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

(2010) Lawrence S. Kegeles et al.   ARCHIVES OF GENERAL PSYCHIATRY

Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats

(2010) Katrina Weston-Green et al.   BEHAVIOURAL BRAIN RESEARCH

Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety

(2010) Caroline Biojone et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns

(2009) Benedetto Vitiello et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects

(2009) Mei Han et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Implications of Marked Weight Gain Associated With Atypical Antipsychotic Medications in Children and Adolescents

(2009) Christopher K. Varley   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Role of dopamine receptors in the ventral tegmental area in conditioned fear

(2008) Amanda Ribeiro de Oliveira et al.   BEHAVIOURAL BRAIN RESEARCH

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom

(2008) F. Rani et al.   PEDIATRICS

Mice lacking the kf-1 gene exhibit increased anxiety- but not despair-like behavior

(2008) Atsushi Tsujimura   Frontiers in Behavioral Neuroscience

Perinatal administration of PCP alters adult behaviour in female Sprague–Dawley rats

(2007) T DUBOIS   BEHAVIOURAL BRAIN RESEARCH

Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice

(2007) Juliana V. Leite et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL